|
Variables
|
Fondaparinux (n = 422)
|
Enoxaparin (n = 453)
|
P
|
|---|
|
MACCEa
|
46 (10.9)
|
57 (12.6)
|
0.433
|
|
Death or MI
|
18 (4.3)
|
24 (5.3)
|
0.475
|
|
Death
|
2 (0.5)
|
7 (1.5)
|
0.116
|
|
MI
|
16 (3.8)
|
17 (3.8)
|
0.976
|
|
TVR
|
23 (5.5)
|
28 (6.2)
|
0.645
|
|
Stroke
|
7 (1.7)
|
9 (2.0)
|
0.717
|
|
30 day
| | | |
|
Major bleeding
|
1 (0.23)
|
4 (0.88)
|
0.429
|
|
All bleedingb
|
4 (0.95)
|
13 (2.9)
|
0.040
|
|
1 year
| | | |
|
Major bleeding
|
1 (0.23)
|
5 (1.1)
|
0.253
|
|
All bleedingb
|
10 (2.4)
|
25 (5.5)
|
0.018
|
-
MI Myocardial infarction, TVR Target vessel revascularization. aMACCE: including death from cardiovascular causes, non-fatal myocardial infarction and target vessel revascularization. bAll bleeding was defined using the TIMI definition. P < 0.05 was considered to indicate statistical significance
